CANNAINVESTOR Magazine North America Privately Held Aug / Sept 2019 | Page 127

Tease them a bit, but be credible. Your NBT doesn’t yet exist? No matter, if it’s tied to what you’re already doing. It’s “in development.”

You’re selling greed, remember. Dangle what they’re looking for — a great return on their investment, with an early exit, perhaps part of some future crazy-priced acquisition.

Don’t skimp on your imagination, just make sure your Next Big Thing sounds plausible, and part of your core business. Investors are conditioned to think that almost anything is possible.

3. Communicate in interesting, easy-to-understand English

Cannabis companies are technology-related, and tend to be described in some kind of techno-babble — almost a foreign language for most people. But when something is hard to read, no one is going to read it. Obvious. Also don’t be afraid to over-simplify your message, just be informative and interesting.

4. Build a great Executive Summary and Pitch Deck

Essential, also obvious — because investors tend to make initial judgements very quickly. Keep in mind …

A bulleted deck and ES need to hook people FAST. You open with a great USP, then quickly lead them through a very factual, logically-flowing pitch.

Fact-packed, yes, but make sure there’s an interesting, plausible narrative running through all the data. (Future projections? Questionable, in my opinion. Who believes that stuff?)

5. Publicly-traded?

A colossal microcap stock boom is coming, rivalling past tech booms. Still, most public cannabis companies will be disappointed, because most CEOs and CFOs don’t understand promotional marketing.

Apart from good timing, there’s almost NOTHING accidental about a stock becoming ‘hot,’, and staying that way. It happens because it was made to happen. Remember, a healthy stock is little more than a manufactured creation. A share of stock is just a product, with a fluctuating value based on supply and demand, requiring constant marketing attention.

Public microcaps that do it right will make a fortune. But most? Not so good. (Roughly 200 cannabis companies are publicly-traded in North America, with most are just a blur. Crazy, shouldn’t happen!)

Partly, this is because most microcaps treat their investors poorly. And that’s really dumb, because a company’s shareholders are its best prospects to buy more shares.